Cosmos Health Inc. (COSM) vs Marker Therapeutics, Inc. (MRKR)

A side-by-side comparison of Cosmos Health Inc. and Marker Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COSM vs MRKR

growth of $100 · dividends reinvested · last 10y
COSM -99.8% (-45.3%/yr)MRKR -98.3% (-33.4%/yr)MRKR compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020182020202220242026$0$2
COSM MRKR

COSM vs MRKR: by the numbers

  • •COSM is the larger company ($18M vs $17M market cap).
  • •Both run net losses; COSM's is the smaller (-33.08% vs -706.23% net margin).

Metrics side by side

Valuation

MetricCOSMMRKR
P/S ratio0.2413.89
P/B ratio0.851.41

Profitability

MetricCOSMMRKR
Gross margin10.27%0.00%
Operating margin-24.65%0.00%
Net margin-33.08%-706.23%
ROE-117.98%-71.57%
ROIC-46.69%-88.07%

Growth (annualized)

MetricCOSMMRKR
Revenue CAGR (5Y)5.24%N/A
Total return CAGR (5Y)-68.41%-42.13%

Frequently asked

How have COSM and MRKR total returns compared?
Over the past 10 years, COSM delivered -45.52% and MRKR delivered -33.25% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.